![]()
|
|
||||||||
J. Biol. Chem., Vol. 267, Issue 28, 19785-19791, Oct, 1992
E Enan, PC Liu and F Matsumura
Toxicity from 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure results
in severe metabolic imbalances leading to a loss of fat stores in many
animal species, a phenomenon known as the wasting syndrome. In this paper,
we report that TCDD treatment at very low doses (0.03-1 micrograms/kg,
single intraperitoneal injection) causes a profound reduction of glucose
uptake by guinea pig adipose tissue, pancreas and brain. This effect of
TCDD is dose-dependent, with a dose as small as 0.03 micrograms/kg
resulting in a significant decrease. In adipose tissue, the decrease begins
within 6 h of treatment and persists at least 28 days. The Vmax of glucose
transport was decreased by TCDD treatment, whereas the Km was unchanged.
Liver behaves oppositely to adipose tissue. At early stages of treatment
(6-12 h) glucose uptake was depressed, while at later stages (24-96 h) it
was increased. In situ (explant tissue culture) treatment with TCDD yields
similar trends as in vivo studies for glucose uptake in all three tissues.
In adipose tissue culture TCDD starts reducing glucose uptake after 30
minutes. The inhibitory potencies of three dioxin congeners on adipose
glucose transporting activities follows the same order of their toxicities
in vivo. TCDD's effect on glucose transport is sensitive to cytochalasin B,
a specific inhibitor of glucose transporter proteins. Based on these
observations and the importance of glucose transporters to cellular energy
maintenance, we conclude that at least in guinea pigs the reduction of
glucose transporters in various tissues is one of the major causes for
TCDD-induced wasting syndrome, which is so prominent in this species.
2,3,7,8-Tetrachlorodibenzo-p-dioxin causes reduction of glucose transporting activities in the plasma membranes of adipose tissue and pancreas from the guinea pig
Department of Environmental Toxicology, University of California, Davis 95616.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Tonack, K. Kind, J. G. Thompson, A. M. Wobus, B. Fischer, and A. N. Santos Dioxin Affects Glucose Transport via the Arylhydrocarbon Receptor Signal Cascade in Pluripotent Embryonic Carcinoma Cells Endocrinology, December 1, 2007; 148(12): 5902 - 5912. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cranmer, S. Louie, R. H. Kennedy, P. A. Kern, and V. A. Fonseca Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Is Associated with Hyperinsulinemia and Insulin Resistance Toxicol. Sci., August 1, 2000; 56(2): 431 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Moreno-Aliaga and F. Matsumura Endrin Inhibits Adipocyte Differentiation by Selectively Altering Expression Pattern of CCAAT/Enhancer Binding Protein-alpha in 3T3-L1 Cells Mol. Pharmacol., July 1, 1999; 56(1): 91 - 101. [Abstract] [Full Text] |
||||
![]() |
M Phillips, E Enan, P. Liu, and F Matsumura Inhibition of 3T3-L1 adipose differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin J. Cell Sci., January 1, 1995; 108(1): 395 - 402. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |